Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, Govindan R, Vansteenkiste J, Meert AP, de Jong WK, Altorki NK, Higashi K, Van Baardwijk A, Borst GR, Ameye L, Lafitte JJ, Berghmans T, Flamen P, Rami-Porta R, Sculier JP. Paesmans M, et al. Among authors: eschmann s. Eur Respir J. 2015 Dec;46(6):1751-61. doi: 10.1183/13993003.00099-2015. Epub 2015 Sep 24. Eur Respir J. 2015. PMID: 26405289 Free article.
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option.
Faehling M, Fallscheer S, Kramberg S, Sträter J, Eschmann S, Sätzler R, Heinzelmann F. Faehling M, et al. Among authors: eschmann s. Eur J Cancer. 2021 Oct;156:175-186. doi: 10.1016/j.ejca.2021.07.035. Epub 2021 Aug 27. Eur J Cancer. 2021. PMID: 34461420
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 223Ra: PARABO, a Prospective, Noninterventional Study.
Palmedo H, Ahmadzadehfar H, Eschmann S, Niesen A, Schönberger J, Barsegian V, Liepe K, Mottaghy FM, Guan R, Pinkert J, Sandström P, Herrmann K. Palmedo H, et al. Among authors: eschmann s. J Nucl Med. 2023 Sep;64(9):1392-1398. doi: 10.2967/jnumed.123.265557. Epub 2023 Jun 29. J Nucl Med. 2023. PMID: 37385670 Free PMC article.
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
Gkika E, Schimek-Jasch T, Kremp S, Lenz S, Stockinger M, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme AH, Dieckmann K, Miederer M, Holl G, Rischke HC, Adebahr S, König J, Binder H, Grosu AL, Nestle U. Gkika E, et al. Among authors: eschmann sm. Radiother Oncol. 2021 Oct;163:32-38. doi: 10.1016/j.radonc.2021.07.017. Epub 2021 Jul 24. Radiother Oncol. 2021. PMID: 34311004 Clinical Trial.
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.
Gkika E, Lenz S, Schimek-Jasch T, Waller CF, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme AH, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Adebahr S, König J, Binder H, Grosu AL, Nestle U. Gkika E, et al. Among authors: eschmann sm. Cancers (Basel). 2020 Nov 13;12(11):3359. doi: 10.3390/cancers12113359. Cancers (Basel). 2020. PMID: 33202825 Free PMC article.
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, König J, Grosu AL; PET-Plan study group. Nestle U, et al. Among authors: eschmann sm. Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171429 Clinical Trial.
64 results